This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ASM journals
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aldwell, F. E.
Right arrow Articles by Buddle, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aldwell, F. E.
Right arrow Articles by Buddle, B. M.

 Previous Article  |  Next Article 

Infection and Immunity, January 2003, p. 101-108, Vol. 71, No. 1
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.1.101-108.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Oral Delivery of Mycobacterium bovis BCG in a Lipid Formulation Induces Resistance to Pulmonary Tuberculosis in Mice

Frank E. Aldwell,1* Ian G. Tucker,2 Geoffrey W. de Lisle,3 and Bryce M. Buddle3

Department of Microbiology,1 School of Pharmacy, University of Otago, Dunedin,2 AgResearch Wallaceville, Upper Hutt, New Zealand3

Received 15 July 2002/ Returned for modification 24 August 2002/ Accepted 15 October 2002

A lipid-based formulation has been developed for oral delivery of Mycobacterium bovis bacille Calmette-Guérin (BCG) vaccine. The formulated M. bovis BCG was fed to BALB/c mice to test for immune responses and protection against M. bovis infection. The immune responses included antigen-specific cytokine responses, spleen cell proliferation, and lymphocyte-mediated macrophage inhibition of M. bovis. Oral delivery of formulated M. bovis BCG to mice induced strong splenic gamma interferon levels and macrophage inhibition of virulent M. bovis compared with results with nonformulated M. bovis BCG. Formulated oral M. bovis BCG significantly reduced the bacterial burden in the spleen and lungs of mice following aerosol challenge with virulent M. bovis. Our data suggest that oral delivery of formulated M. bovis BCG is an effective means of inducing protective immune responses against tuberculosis. Lipid-based, orally delivered mycobacterial vaccines may be a safe and practical method of controlling tuberculosis in humans and animals.

* Corresponding author. Mailing address: Department of Microbiology, University of Otago, P.O. Box 56, Dunedin, New Zealand. Phone: 64 34795931. Fax: 64 34778540. E-mail: frank.aldwell{at}stonebow.otago.ac.nz.

Editor: W. A. Petri, Jr.

Infection and Immunity, January 2003, p. 101-108, Vol. 71, No. 1
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.1.101-108.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Cross, M. L., Lambeth, M. R., Aldwell, F. E. (2009). An Oral Mycobacterium bovis BCG Vaccine for Wildlife Produced in the Absence of Animal-Derived Reagents. CVI 16: 1378-1380 [Abstract] [Full Text]  
  • Tompkins, D. M., Ramsey, D. S. L., Cross, M. L., Aldwell, F. E., de Lisle, G. W., Buddle, B. M. (2009). Oral vaccination reduces the incidence of tuberculosis in free-living brushtail possums. Proc R Soc B 276: 2987-2995 [Abstract] [Full Text]  
  • Cross, M. L., Henderson, R. J., Lambeth, M. R., Buddle, B. M., Aldwell, F. E. (2009). LIPID-FORMULATED BCG AS AN ORAL-BAIT VACCINE FOR TUBERCULOSIS: VACCINE STABILITY, EFFICACY, AND PALATABILITY TO BRUSHTAIL POSSUMS (TRICHOSURUS VULPECULA) IN NEW ZEALAND. J Wildl Dis 45: 754-765 [Abstract] [Full Text]  
  • Clark, S., Cross, M. L., Nadian, A., Vipond, J., Court, P., Williams, A., Hewinson, R. G., Aldwell, F. E., Chambers, M. A. (2008). Oral Vaccination of Guinea Pigs with a Mycobacterium bovis Bacillus Calmette-Guerin Vaccine in a Lipid Matrix Protects against Aerosol Infection with Virulent M. bovis. Infect. Immun. 76: 3771-3776 [Abstract] [Full Text]  
  • Nol, P., Palmer, M. V., Waters, W. R., Aldwell, F. E., Buddle, B. M., Triantis, J. M., Linke, L. M., Phillips, G. E., Thacker, T. C., Rhyan, J. C., Dunbar, M. R., Salman, M. D. (2008). EFFICACY OF ORAL AND PARENTERAL ROUTES OF MYCOBACTERIUM BOVIS BACILLE CALMETTE-GUERIN VACCINATION AGAINST EXPERIMENTAL BOVINE TUBERCULOSIS IN WHITE-TAILED DEER (ODOCOILEUS VIRGINIANUS): A FEASIBILITY STUDY. J Wildl Dis 44: 247-259 [Abstract] [Full Text]  
  • Aldwell, F. E., Brandt, L., Fitzpatrick, C., Orme, I. M. (2005). Mice Fed Lipid-Encapsulated Mycobacterium bovis BCG Are Protected against Aerosol Challenge with Mycobacterium tuberculosis. Infect. Immun. 73: 1903-1905 [Abstract] [Full Text]  
  • Collins, D. M., Kawakami, R. P., Buddle, B. M., Wards, B. J., de Lisle, G. W. (2003). Different susceptibility of two animal species infected with isogenic mutants of Mycobacterium bovis identifies phoT as having roles in tuberculosis virulence and phosphate transport. Microbiology 149: 3203-3212 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»